𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B virus strains in Thailand: Genomic variants in chronic carriers

✍ Scribed by Dr. Karin Kidd-Ljunggren; Karl Ekdahl; Monica Öberg; Sucha Kurathong; Somsak Lolekha


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
792 KB
Volume
47
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Genetic heterogeneity of the hepatitis B virus (HBV) has been shown to influence the serological pattern and clinical picture in HBV infection. Thailand has a high transmission rate of HBV, but the molecular epidemiology of HBV strains circulating in this region was hitherto unknown. In this study, the HBV strains from 34 Thai HBsAg‐positive patients were investigated. In a proportion of these samples, an antigenically important region of the S gene (n = 181, and the pre‐S2 and precore genes (n = 15) were sequenced after PCR amplification. Four strains had in‐frame deletions of an upstream region of the pre‐S2 gene, with all deletions ending at the same nucleotide. In one of three anti‐HBe positive strains without a translational stop at codon 28 of the precore gene, there was a one nucleotide insertion in the precore gene. This insertion would cause a frame shift and result in a nonsense protein being expressed, thus providing one explanation for the lack of HBeAg in this patient. Several rare or unique amino acid changes in the region between residues 120 and 161 of the S protein were found. Glycine 145 was changed to alanine in one strain, and this position showed an apparent mixture of glycine and arginine in another. In total, 10 strains displayed unexpected changes that were not related to the normal variability between subtypes or genetic subgroups. It is concluded that there is considerable heterogeneity in HBV strains in Thailand and that this could have clinical and epidemiological importance in a region with high HBV transmission rates. © Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Frequency of hepatitis B virus ‘a’ deter
✍ Ana Avellón; José M. Echevarria 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract The prevalence in the population of hepatitis B virus (HBV) surface antigen (HBsAg) variants that may impair diagnosis, or allow the virus to escape vaccine‐induced immunity or passive immunoglobulin therapy is unknown. A genome fragment encoding HBsAg amino acids 112–212 was amplified

Hepatitis A Infection in Chronic Carrier
✍ Reinhart Zachoval; Michael Roggendorf; Friedrich Deinhardt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 2 views

By routine screening for serologic markers of hepatitis A and B in patients with acute hepatitis, 30 chronic carriers of hepatitis B virus with serologic evidence of acute hepatitis A and two patients with simultaneous acute infection with hepatitis A virus and hepatitis B virus were detected. For

Foscarnet therapy in chronic hepatitis B
✍ V. G. Bain; H. M. Daniels; A. Chanas; G. J. M. Alexander; Dr. Roger Williams 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 2 views

Foscarnet (trisodium phosphonoformate) is a novel antiviral agent that inhibits viral-specific DNA polymerase. In the present study, eight males with chronic HBV carriage (HBeAg and HBV-DNA seropositivity >I2 months) showing chronic persistent hepatitis (CPH) or chronic active hepatitis (CAH) on liv

Serial passage of hepatitis delta virus
✍ Antonio Ponzetto; Francesco Negro; Hans Popper; Ferruccio Bonino; Ronald Engle; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 898 KB

Five consecutive passages of hepatitis delta virus in hepatitis B virus carrier chimpanzees were performed in order to further characterize the infectious and pathogenic nature of this naturally occurring defective virus. Three animals received identical inocula at fourth passage in order to assess

Liver disease activity and hepatitis B v
✍ Stephanos J. Hadziyannis; Morris Sherman; Harvey M. Lieberman; David A. Shafritz 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Delta antigen is currently thought to reflect superinfection of the liver with a defective RNA virus (delta agent), requiring helper function from hepatitis B virus for its replication. To assess the influence of delta agent on hepatitis B virus replication in patients persistently infected with bot